Fixed dose (555 MBq; 15 mCi) radioiodine for the treatment of hyperthyroidism: outcome and its predictors

Title: Fixed dose (555 MBq; 15 mCi) radioiodine for the treatment of hyperthyroidism: outcome and its predictors
Creator: Gupta, S. K.; McGrath, S.; Rogers, K.; Attia, J.; Lewis, G.; Viswanathan, S.; Saul, M.; Allen, L.
Relation: Internal Medicine Journal Vol. 40, Issue 12, p. 854-857
Publisher Link: http://dx.doi.org/10.1111/j.1445-5994.2010.02348.x
Publisher: Wiley-Blackwell Publishing Asia
Resource Type: journal article
Date: 2010
Description: Radioiodine therapy (RIT) is an accepted treatment for hyperthyroidism and a 555-MBq (15-mCi) dose is frequently used. We aimed to assess treatment outcome with this dose, and to identify predictors of successful treatment. An analysis of 478 treated patients demonstrated an overall four-month cure rate of 79.5%; success rate was higher in patients with toxic multinodular goitre, solitary toxic adenoma, a smaller thyroid or less severe disease. This information may be of further assistance if variation in the dose of RIT is considered.
Subject: radioiodine therapy; hyperthyroidism; thyrotoxicosis; fixed dose; 555 MBq; uptake ratio
Identifier: http://hdl.handle.net/1959.13/929310
Identifier: uon:10561
Identifier: ISSN:1444-0903
Language: eng
Reviewed

		Thumbnail	File	Description	Size	Format